Aikaeli, Faith, Njim, Tsi, Gissing, Stefanie, Moyo, Faith, Alam, Uazman, Mfinanga, Sayoki, Okebe, Joseph ORCID: https://orcid.org/0000-0001-5466-1611, Ramaiya, Kaushik, Webb, Emily L., Jaffar, Shabbar ORCID: https://orcid.org/0000-0002-9615-1588 and Garrib, Anupam ORCID: https://orcid.org/0000-0003-2305-3749 (2022) 'Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis'. PLOS Global Public Health, Vol 2, Issue 6, e0000599.
|
Text
pgph.0000599.pdf - Published Version Available under License Creative Commons Attribution. Download (3MB) | Preview |
Abstract
There is an excessive burden of diabetes complications in low-resource settings. We conducted a systematic review to determine the nature and frequency of diabetes complications in newly diagnosed with type 2 diabetes. A systematic search was performed using Medline, CINAHL and Global Health online databases from inception to July 2020. Articles reporting prevalence of microvascular or macrovascular complications within six months of type 2 diabetes diagnosis and published in English or French from low- and middle-income countries (LMICs) were eligible for analysis. Data were extracted using a standardized data extraction tool. Descriptive statistics were used to describe the prevalence of micro and macrovascular complications in newly diagnosed type 2 diabetes. Assessment of heterogeneity was conducted using the inconsistency index (I2) and Cochran-Q chi2 statistical tests. Publication bias was assessed by the Funnel plot and Egger test. A total of 3 292 records underwent title or abstract screening and 95 articles underwent full text review. Thirty-three studies describing 13 283 participants (aged 20 years and older) met the inclusion criteria. The eligible studies were from Asia (n = 24), Africa (n = 4), Oceania (n = 2), South America (n = 2) and the Caribbean (n = 1). For microvascular complications, the median prevalence (interquartile range) of retinopathy, nephropathy and neuropathy were 12% (6%-15%), 15% (7%-35%) and 16% (10%25%) respectively. For macrovascular complications, the median prevalence (interquartile range) was 10% (7%-17%) for ischaemic heart disease, 6% (1%-20%) for peripheral arterial disease and 2% (1%-4%) for stroke. There was evidence of substantial heterogeneity between studies for all outcomes (I2 > 90%. We found a high prevalence of complications in newly diagnosed type 2 diabetes in LMICs. Findings suggest that many people live with diabetes and are only diagnosed when they present with complications in LMICs. Research is needed to guide timely and effective identification of people living with diabetes in these settings.
Item Type: | Article |
---|---|
Subjects: | WA Public Health > WA 30 Socioeconomic factors in public health (General) WK Endocrine System > WK 810 Diabetes mellitus WK Endocrine System > WK 835 Complications of diabetes |
Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department Clinical Sciences & International Health > International Public Health Department |
Digital Object Identifer (DOI): | https://doi.org/10.1371/journal.pgph.0000599 |
SWORD Depositor: | JISC Pubrouter |
Depositing User: | JISC Pubrouter |
Date Deposited: | 24 Nov 2022 11:30 |
Last Modified: | 13 Jun 2023 11:04 |
URI: | https://archive.lstmed.ac.uk/id/eprint/20593 |
Statistics
Actions (login required)
Edit Item |